FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
NCT00309088 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2014-08-25
Summary
The purpose of the study is to investigate the efficacy and safety for steroid non-resistant MG patients in a double blind, placebo controlled study.
Conditions
Interventions
- DRUG
-
oral
- DRUG
-
oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- Japan
More Related Trials
-
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
NCT01325571 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
NCT00727194 ·Status: TERMINATED ·Phase: PHASE2
-
Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis
NCT05218096 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Allogeneic CD19-CAR-NK Cells in Patients With Refractory Myasthenia Gravis
NCT07243366 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
NCT06106672 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis(24103)
NCT07058298 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
NCT06517758 ·Status: RECRUITING ·Phase: PHASE3
-
A Prospective Cohort Study of Myasthenia Gravis in China
NCT06006832 ·Status: RECRUITING
-
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Eculizumab in Chinese Adults With gMG
NCT06764160 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
NCT04768465 ·Status: UNKNOWN
-
An Exploratory Clinical Study of GC012F Injection for Refractory gMG
NCT06419166 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis
NCT01555580 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis
NCT04115293 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Telitacicept in Generalized Myasthenia Gravis
NCT05737160 ·Status: COMPLETED ·Phase: PHASE3
-
An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
NCT03669588 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis
NCT00987116 ·Status: COMPLETED ·Phase: PHASE4
-
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
NCT06723548 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Mycophenolate Mofetil in Myasthenia Gravis
NCT00285350 ·Status: COMPLETED ·Phase: PHASE3
-
Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study
NCT04431895 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan
NCT02835742 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
NCT07039916 ·Status: RECRUITING ·Phase: PHASE3